Global Microcrystalline Cellulose Market

$4,450$6,250

The global Microcrystalline Cellulose Market is expected to exhibit a healthy CAGR of 6.78% to surpass USD 1,204.7 Million by the forecast period 2027. Microcrystalline cellulose (MCC) is a refined wood mash utilized as an enemy of a building up specialist, an emulsifier, a fat substitute, a texturizer, an extender, and a building specialist.

Clear

Description

Global Microcrystalline Cellulose Market: Forecast till 2027

Market Overview
The global Microcrystalline Cellulose Market is expected to exhibit a healthy CAGR of 6.78% to surpass USD 1,204.7 Million by the forecast period 2027. Microcrystalline cellulose (MCC) is a refined wood mash utilized as an enemy of a building up specialist, an emulsifier, a fat substitute, a texturizer, an extender, and a building specialist. It is ordinarily utilized as tablets or enhancements. It is created by controlled hydrolysis of profoundly filtered alpha-cellulose, acquired from normally happening wood cellulose with mineral acids. Microcrystalline cellulose is also applicable in personal care and cosmetic products, creating profitable opportunities for market players.
Microcrystalline Cellulose Market is expected to witness a substantial market growth rate during the forecast period. The regional market growth is driven by the increasing demand for MCC as pharmaceutical excipients. Moreover, the increasing food & beverage industry, changing consumer lifestyles, growing per capita disposable income, and rising purchasing power of the people are expected to witness the largest market growth of the microcrystalline cellulose market during the forecast period. However, the availability of microcrystalline cellulose substitutes is expected to restrain the growth of this market.
Market Segmentation
Global Microcrystalline Cellulose Market has been classified into Source, End-Use Industry, and Region.
Based on source type, the Global Microcrystalline Cellulose Market has been divided into wood-based and non-wood-based. The wood-based source segment is expected to register the highest market growth owing to more than 50% of the global market share in 2019. This polymer is widely used as a non-stick coating for pans and cookware, insulation of wiring in aerospace and electrical industries, medical appliances, and automotive and industrial products.
In terms of the end-use industry, the microcrystalline cellulose market has been classified into pharmaceutical, food & beverages, cosmetics & personal care, and others. The pharmaceutical segment led the global market with more than 40% market share in 2019. among people. The food & beverage segment is evaluated to hold a significant market share in the global microcrystalline cellulose market.
Regional Analysis
Geographically, the Microcrystalline Cellulose Market has been spread across five regions, namely, Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa.
The market in Asia-Pacific accounted for the largest market share of more than 40% market in 2019, with a market value of approximately USD 587.3 million. The regional market growth is driven by the increasing urbanization and growing industrialization in the developing economies of Asia-Pacific, especially in China, Japan, and southeast Asian nations.
North America held the second-largest market share owing to the existence of established players in the region, with the US being the largest market.
Major Players
The Major players operating in the global microcrystalline cellulose market are DuPont, Asahi Kasei Corporation, JRS Pharma, Roquette Frères, Mingtai Chemical Co., Ltd., Accent Microcell Pvt. Ltd., JRS Pharma, Pharmatrans-Sanaq AG, DFE Pharma, Weiming Pharmaceutical MFG. Co., Ltd, and Sigachi Industries Pvt. Ltd.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT
1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVENESS ANALYSIS 18

1.1.1 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY SOURCE 18

1.1.2 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY END-USE INDUSTRY 19

1.1.3 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY REGION 20

2 MARKET INTRODUCTION

2.1 DEFINITION 21

2.2 SCOPE OF THE STUDY 21

2.3 MARKET STRUCTURE 22

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 23

3.2 PRIMARY RESEARCH 24

3.3 SECONDARY RESEARCH 25

3.4 MARKET SIZE ESTIMATION 25

3.5 TOP-DOWN AND BOTTOM-UP APPROACH 26

3.6 FORECAST MODEL 27

3.7 LIST OF ASSUMPTIONS 28

4 MARKET DYNAMICS

4.1 INTRODUCTION 29

4.2 DRIVERS 30

4.2.1 INCREASING DEMAND OF MICROCRYSTALLINE CELLULOSE IN PHARMACEUTICAL INDUSTRY 30

4.2.2 SUSTAINABLE GROWTH OF DEMAND IN PROCESSED FOOD INDUSTRY 30

4.3 RESTRAINT 31

4.3.1 AVAILABILITY OF SUBSTITUTES 31

4.4 OPPORTUNITIES 32

4.4.1 DEVELOPMENT AND USE OF NON-WOOD BASED MICROCRYSTALLINE CELLULOSE IN THE GLOBAL MARKET 32

4.4.2 INCREASING USE OF MICROCRYSTALLINE CELLULOSE FOR COSMETICS AND PERSONAL CARE PRODUCTS 32

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS 34

5.1.1 RAW MATERIAL SUPPLIERS 34

5.1.2 MICROCRYSTALLINE CELLULOSE MANUFACTURERS 35

5.1.3 DISTRIBUTION & SALES CHANNEL 35

5.1.4 END USE 35

5.2 PORTER’S FIVE FORCES ANALYSIS 36

5.2.1 THREAT OF NEW ENTRANTS 36

5.2.2 INTENSITY OF COMPETITIVE RIVALRY 37

5.2.3 THREAT OF SUBSTITUTES 37

5.2.4 BARGAINING POWER OF SUPPLIERS 37

5.2.5 BARGAINING POWER OF BUYERS 37

5.3 PRICING OVERVIEW, USD/TON (2018–2020) 37

5.4 IMPACT OF COVID-19 ON THE MICROCRYSTALLINE CELLULOSE INDUSTRY 38

5.4.1 OVERVIEW OF SUPPLY SCENARIO 38

5.4.2 IMPACT OF COVID-19 ON THE SUPPLY CHAIN OF MICROCRYSTALLINE CELLULOSE 38

5.4.2.1 RAW MATERIALS 38

5.4.2.1 MICROCRYSTALLINE CELLULOSE MANUFACTURERS 38

5.4.2.2 SALES & DISTRIBUTION CHANNELS 38

5.4.2.3 END USERS 39

5.4.3 QUALITATIVE ANALYSIS ON CHANGE IN DEMAND DUE TO COVID-19 39

5.4.4 IMPACT OF COVID ON GLOBAL ECONOMY 40

5.4.5 NUMBER OF COVID-19 CASES 41

5.4.6 MAJOR GOVERNMENT POLICIES TO COUNTER THE IMPACT OF COVID-19 42

5.4.6.1 US 42

5.4.6.1.1 FISCAL POLICIES 42

5.4.6.1.2 MONETARY AND MACRO-FINANCIAL 42

5.4.6.2 EUROPEAN UNION 42

5.4.6.2.1 FISCAL POLICIES 42

5.4.6.2.2 MONETARY AND MACRO-FINANCIAL 43

5.4.6.3 CHINA 43

5.4.6.3.1 FISCAL POLICIES 43

5.4.6.3.2 MONETARY AND MACRO-FINANCIAL 43

5.4.6.4 INDIA 44

5.4.6.4.1 FISCAL POLICIES 44

5.4.6.4.2 MONETARY AND MACRO-FINANCIAL 44

6 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY SOURCE

6.1 OVERVIEW 45

6.1.1 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY SOURCE, 2018–2027 46

6.1.2 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY SOURCE, 2018–2027 47

6.2 WOOD BASED 48

6.2.1 WOOD BASED: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 48

6.3 NON-WOOD BASED 49

6.3.1 NON-WOOD BASED: MARKET ESTIMATES & FORECAST BY REGION,2018–2027 49

7 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY END-USE INDUSTRY

7.1 OVERVIEW 51

7.1.1 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY END-USE INDUSTRY, 2018–2027 52

7.1.2 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY END-USE INDUSTRY, 2017–2025 53

7.2 PHARMACEUTICALS 54

7.2.1 PHARMACEUTICALS: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 54

7.2.2 PHARMACEUTICALS: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 54

7.3 FOOD & BEVERAGE 55

7.3.1 FOOD & BEVERAGE: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 55

7.3.2 FOOD & BEVERAGE: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 56

7.4 COSMETIC & PERSONAL CARE 56

7.4.1 COSMETIC & PERSONAL CARE: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 56

7.4.2 COSMETIC & PERSONAL CARE: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 57

7.5 OTHERS 57

7.5.1 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 57

7.5.2 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2018–2027 58

8 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY REGION

8.1 OVERVIEW 59

8.2 NORTH AMERICA 63

8.2.1 US 66

8.2.2 CANADA 67

8.3 EUROPE 70

8.3.1 GERMANY 73

8.3.2 UK 75

8.3.3 RUSSIA 76

8.3.4 FRANCE 78

8.3.5 SPAIN 80

8.3.6 ITALY 81

8.3.7 REST OF EUROPE 83

8.4 ASIA-PACIFIC 85

8.4.1 CHINA 88

8.4.2 JAPAN 90

8.4.3 INDIA 91

8.4.4 SOUTH KOREA 93

8.4.5 AUSTRALIA & NEW ZEALAND 95

8.4.6 INDONESIA 97

8.4.7 THAILAND 98

8.4.8 REST OF ASIA-PACIFIC 100

8.5 MIDDLE EAST & AFRICA 102

8.5.1 GCC 105

8.5.2 ISRAEL 106

8.5.3 SOUTH AFRICA 108

8.5.4 REST OF MIDDLE EAST & AFRICA 110

8.6 LATIN AMERICA 112

8.6.1 BRAZIL 115

8.6.2 MEXICO 116

8.6.3 ARGENTINA 118

8.6.4 REST OF LATIN AMERICA 120

9 COMPETITIVE LANDSCAPE

9.1 COMPETITIVE OVERVIEW 122

9.2 GLOBAL MARKET STRATEGY ANALYSIS 122

9.3 COMPETITIVE BENCHMARKING 123

10 COMPANY PROFILES

10.1 DUPONT 124

10.1.1 COMPANY OVERVIEW 124

10.1.2 FINANCIAL OVERVIEW 125

10.1.3 PRODUCTS OFFERED 126

10.1.4 KEY DEVELOPMENTS 126

10.1.5 SWOT ANALYSIS 127

10.1.6 KEY STRATEGIES 127

10.2 ASAHI KASEI CORPORATION 128

10.2.1 COMPANY OVERVIEW 128

10.2.2 FINANCIAL OVERVIEW 129

10.2.3 PRODUCTS OFFERED 130

10.2.4 KEY DEVELOPMENTS 130

10.2.5 SWOT ANALYSIS 131

10.2.6 KEY STRATEGIES 131

10.3 ROQUETTE FRÈRES 132

10.3.1 COMPANY OVERVIEW 132

10.3.2 FINANCIAL OVERVIEW 132

10.3.3 PRODUCTS OFFERED 132

10.3.4 KEY DEVELOPMENTS 132

10.3.5 SWOT ANALYSIS 133

10.3.6 KEY STRATEGIES 133

10.4 MINGTAI CHEMICAL CO., LTD 134

10.4.1 COMPANY OVERVIEW 134

10.4.2 FINANCIAL OVERVIEW 134

10.4.3 PRODUCTS OFFERED 134

10.4.4 KEY DEVELOPMENTS 134

10.4.5 SWOT ANALYSIS 135

10.4.6 KEY STRATEGIES 135

10.5 ACCENT MICROCELL PVT. LTD 136

10.5.1 COMPANY OVERVIEW 136

10.5.2 FINANCIAL OVERVIEW 136

10.5.3 PRODUCTS OFFERED 136

10.5.4 KEY DEVELOPMENTS 136

10.5.5 SWOT ANALYSIS 137

10.5.6 KEY STRATEGIES 137

10.6 JRS PHARMA 138

10.6.1 COMPANY OVERVIEW 138

10.6.2 FINANCIAL OVERVIEW 138

10.6.3 PRODUCTS OFFERED 138

10.6.4 KEY DEVELOPMENTS 139

10.6.5 SWOT ANALYSIS 140

10.6.6 KEY STRATEGIES 140

10.7 PHARMATRANS-SANAQ AG 141

10.7.1 COMPANY OVERVIEW 141

10.7.2 FINANCIAL OVERVIEW 141

10.7.3 PRODUCTS OFFERED 141

10.7.4 KEY DEVELOPMENTS 141

10.7.5 SWOT ANALYSIS 142

10.7.6 KEY STRATEGIES 142

10.8 DFE PHARMA 143

10.8.1 COMPANY OVERVIEW 143

10.8.2 FINANCIAL OVERVIEW 143

10.8.3 PRODUCTS OFFERED 143

10.8.4 KEY DEVELOPMENTS 143

10.8.5 SWOT ANALYSIS 144

10.8.6 KEY STRATEGIES 144

10.9 WEI MING PHARMACEUTICAL MFG. CO., LTD 145

10.9.1 COMPANY OVERVIEW 145

10.9.2 FINANCIAL OVERVIEW 145

10.9.3 PRODUCTS OFFERED 145

10.9.4 KEY DEVELOPMENTS 145

10.9.5 SWOT ANALYSIS 146

10.9.6 KEY STRATEGIES 146

10.10 SIGACHI INDUSTRIES PVT.LTD. 147

10.10.1 COMPANY OVERVIEW 147

10.10.2 FINANCIAL OVERVIEW 147

10.10.3 PRODUCTS OFFERED 147

10.10.4 KEY DEVELOPMENTS 147

10.10.5 SWOT ANALYSIS 148

10.10.6 KEY STRATEGIES 148

11 APPENDIX

11.1 REFERENCES 149

11.2 RELATED REPORTS 149